Darunavir and Cardiovascular Risk: Evaluating the Data to Inform Clinical Care-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Darunavir and Cardiovascular Risk: Evaluating the Data to Inform Clinical Care

Published:2019-12-11 Issue:4 Volume:221 Page:498-500
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Triant Virginia A¹²³⁴^ORCID,Siedner Mark J¹³⁴⁵

Affiliation:

1. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA

2. Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA

3. Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA

4. Harvard Medical School, Boston, Massachusetts, USA

5. Africa Health Research Institute, KwaZulu-Nata, South Africa

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiz482/31498297/jiz482.pdf

Reference18 articles.

1. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association;Feinstein;Circulation,2019

2. Class of antiretroviral drugs and the risk of myocardial infarction;Friis-Moller;N Engl J Med,2007

3. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration;Sabin;Lancet,2008

4. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study;Ryom;The lancet HIV,2018

5. Weight gain associated with integrase stand transfer inhibitor use in women;Kerchberger;Clin Infect Dis,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching Human Immunodeficiency Virus Therapy;Infectious Disease Clinics of North America;2024-09

2. Pathogenesis of COVID19 and the applications of US FDA-approved repurposed antiviral drugs to combat SARS-CoV-2 in Saudi Arabia: A recent update by review of literature;Saudi Journal of Biological Sciences;2024-07

3. COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development;BioMed Research International;2023-08-29

4. Cardiovascular Disease and Thrombosis in HIV Infection;Arteriosclerosis, Thrombosis, and Vascular Biology;2023-02

5. Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha;Frontiers in Oncology;2022-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3